CVS Health (CVS) valuation
CVS Health P/E ratio history
CVS Health trades at 23.8 times its earnings over the last twelve months and 10.9 times the earnings analysts expect over the next twelve. At its last 9 fiscal year ends its P/E ranged from 11.2 (year to Dec 2017) to 57.1 (year to Dec 2025), with a median of 14.6.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $79.36 | $1.39 | 57.1 | 11.3 |
| Dec 31, 2024 | $44.89 | $3.66 | 12.3 | 7.5 |
| Dec 31, 2023 | $78.96 | $6.47 | 12.2 | 9.3 |
| Dec 31, 2022 | $93.19 | $3.26 | 28.6 | 10.6 |
| Dec 31, 2021 | $103.16 | $6.02 | 17.1 | 12.6 |
| Dec 31, 2020 | $68.30 | $5.46 | 12.5 | — |
| Dec 31, 2019 | $74.29 | $5.08 | 14.6 | — |
| Dec 31, 2018 | $65.52 | -$0.55 | n/m | — |
| Dec 31, 2017 | $72.50 | $6.47 | 11.2 | — |
| Dec 31, 2016 | $78.91 | $4.92 | 16.0 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
CVS Health valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| CVS HealthCVS | $115B | 23.8 | 10.9 | 0.3 |
| McKessonMCK | $120B | 26.7 | 21.5 | 0.3 |
| HCA HealthcareHCA | $102B | 15.7 | 15.3 | 1.3 |
| Elevance HealthELV | $91.2B | 17.8 | 14.0 | 0.5 |
| CignaCI | $78.9B | 12.3 | 9.3 | 0.3 |
| Cardinal HealthCAH | $58.7B | 34.6 | — | 0.2 |
| Veeva SystemsVEEV | $50.8B | 51.2 | 32.1 | 14.7 |
| HumanaHUM | $49.8B | 39.1 | 31.6 | 0.3 |
| UnitedHealth GroupUNH | $370B | 26.1 | 18.0 | 0.8 |
| Peer median | 26.4 | 18.0 | 0.4 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: CVS financials · CVS returns
No forecast, no recommendation. This page describes CVS Health from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.